Literature DB >> 26401896

Aflibercept anti-vascular endothelial growth factor therapy in vitrectomized eyes with neovascular age-related macular degeneration.

Jesse J Jung1,2,3, Quan V Hoang1, Mohammad Z Y Arain1, Stanley Chang1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 26401896      PMCID： PMC4808506          DOI： 10.1111/aos.12840

Source DB:  PubMed          Journal:  Acta Ophthalmol        ISSN： 1755-375X            Impact factor:   3.761


× No keyword cloud information.
  6 in total

1.  Intraocular pharmacokinetics of ranibizumab in vitrectomized versus nonvitrectomized eyes.

Authors:  Seong Joon Ahn; Jeeyun Ahn; Sunyoung Park; Hyuncheol Kim; Duck Jin Hwang; Ji Hyun Park; Ji Yeon Park; Jae Yong Chung; Kyu Hyung Park; Se Joon Woo
Journal:  Invest Ophthalmol Vis Sci       Date:  2014-01-29       Impact factor: 4.799

2.  Predicted biological activity of intravitreal VEGF Trap.

Authors:  M W Stewart; P J Rosenfeld
Journal:  Br J Ophthalmol       Date:  2008-03-20       Impact factor: 4.638

3.  Diffusion characteristics of vitreous humour and saline solution follow the Stokes Einstein equation.

Authors:  Svanborg Gisladottir; Thorsteinn Loftsson; Einar Stefansson
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2009-07-29       Impact factor: 3.117

4.  Anatomic and pharmacokinetic properties of intravitreal bevacizumab and ranibizumab after vitrectomy and lensectomy.

Authors:  John B Christoforidis; Michelle M Williams; Jillian Wang; Angela Jiang; Cedric Pratt; Mahmoud Abdel-Rasoul; George H Hinkle; Michael V Knopp
Journal:  Retina       Date:  2013-05       Impact factor: 4.256

5.  Intravitreal aflibercept injection for neovascular age-related macular degeneration: ninety-six-week results of the VIEW studies.

Authors:  Ursula Schmidt-Erfurth; Peter K Kaiser; Jean-François Korobelnik; David M Brown; Victor Chong; Quan Dong Nguyen; Allen C Ho; Yuichiro Ogura; Christian Simader; Glenn J Jaffe; Jason S Slakter; George D Yancopoulos; Neil Stahl; Robert Vitti; Alyson J Berliner; Yuhwen Soo; Majid Anderesi; Olaf Sowade; Oliver Zeitz; Christiane Norenberg; Rupert Sandbrink; Jeffrey S Heier
Journal:  Ophthalmology       Date:  2013-09-29       Impact factor: 12.079

6.  Successful treatment of neovascular age-related macular degeneration following single bevacizumab failure using aflibercept in a vitrectomized eye.

Authors:  Paul Hahn
Journal:  Clin Ophthalmol       Date:  2014-10-17
  6 in total
  2 in total

1.  Eyes that Do Not Meet the Eligibility Criteria of Clinical Trials on Age-Related Macular Degeneration: Proportion of the Real-World Patient Population and Reasons for Exclusion.

Authors:  Jae Hui Kim; Jong Woo Kim; Chul Gu Kim
Journal:  J Ophthalmol       Date:  2021-04-17       Impact factor: 1.909

2.  Long-Term Outcome of Eyes with Vitrectomy for Submacular and/or Vitreous Hemorrhage in Neovascular Age-Related Macular Degeneration.

Authors:  Setsuko Kawakami; Yoshihiro Wakabayashi; Kazuhiko Umazume; Yoshihiko Usui; Daisuke Muramatsu; Tsuyoshi Agawa; Kaori Yamamoto; Hiroshi Goto
Journal:  J Ophthalmol       Date:  2021-11-02       Impact factor: 1.909
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.